Effects of MCH/NEI in the striatum and interactions between them and with alpha-MSH on IP3 levels

Mónica Silvina Sanchez1, Victoria Berberian, María Ester Celis

  • 1Laboratorio de Fisiología, Departmento de Farmacología, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Casilla de Correos 61, Agencia Postal 4, Córdoba, Argentina.

Peptides
|June 27, 2002
PubMed

Insights

Melanocyte concentrating hormone (MCH) increased inositol trisphosphate (IP3) levels in brain slices. However, neuropeptide glutamine (E)-isoleusine-(I) (NEI) and alpha-melanocyte-stimulating-hormone (alpha-MSH) blocked this effect, suggesting complex peptide interactions.

Area of Science:

  • Neuroendocrinology
  • Molecular Neuroscience

Background:

  • Inositol trisphosphate (IP3) is a crucial second messenger in intracellular signaling pathways.
  • Melanocyte concentrating hormone (MCH) and other neuropeptides play roles in regulating neuronal activity and behavior.
  • Understanding the interplay of these signaling molecules is vital for deciphering brain function.

Purpose of the Study:

  • To investigate the effects of MCH and NEI on IP3 production in specific brain regions.
  • To examine the interactions between MCH, NEI, and alpha-MSH on IP3 signaling.
  • To elucidate the role of these peptides in modulating intracellular calcium signaling.

Main Methods:

  • Utilized an in vitro model with brain slices from caudate putamen (CP) and accumbens nuclei (ACC).
  • Measured IP3 production in response to varying concentrations of MCH, NEI, and alpha-MSH.
  • Assessed the impact of combined peptide treatments on IP3 levels.

Main Results:

  • MCH significantly increased IP3 production at a high concentration (3.6 microM) but not at a low concentration (0.6 microM).
  • NEI and alpha-MSH alone did not alter IP3 levels at tested concentrations.
  • Co-administration of NEI or alpha-MSH with MCH blocked the MCH-induced increase in IP3.

Conclusions:

  • MCH modulates IP3 production in the CP and ACC, indicating its involvement in intracellular signaling in these areas.
  • NEI and alpha-MSH act as antagonists to MCH's effect on IP3 production.
  • These findings highlight complex regulatory mechanisms involving MCH, NEI, and alpha-MSH in brain signaling pathways.